ID: ALA4539788

Max Phase: Preclinical

Molecular Formula: C35H42N6O5S

Molecular Weight: 658.82

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cc(S(=O)(=O)N2CCCC2)ccc1-c1ccc(C[C@H](NC(=O)[C@H]2CC[C@H](CN)CC2)C(=O)Nc2ccc3c(=O)[nH][nH]c3c2)cc1

Standard InChI:  InChI=1S/C35H42N6O5S/c1-22-18-28(47(45,46)41-16-2-3-17-41)13-15-29(22)25-8-4-23(5-9-25)19-32(38-33(42)26-10-6-24(21-36)7-11-26)35(44)37-27-12-14-30-31(20-27)39-40-34(30)43/h4-5,8-9,12-15,18,20,24,26,32H,2-3,6-7,10-11,16-17,19,21,36H2,1H3,(H,37,44)(H,38,42)(H2,39,40,43)/t24-,26-,32-/m0/s1

Standard InChI Key:  YKEUPPOASIWEHM-BAMJFLLESA-N

Associated Targets(Human)

Plasminogen 2339 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Coagulation factor XI 1733 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 658.82Molecular Weight (Monoisotopic): 658.2937AlogP: 4.05#Rotatable Bonds: 10
Polar Surface Area: 170.25Molecular Species: BASEHBA: 6HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.76CX Basic pKa: 10.40CX LogP: 3.79CX LogD: 1.91
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.17Np Likeness Score: -1.23

References

1. Steinmetzer T, Pilgram O, Wenzel BM, Wiedemeyer SJA..  (2020)  Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding.,  63  (4): [PMID:31658420] [10.1021/acs.jmedchem.9b01060]

Source